Outcome of patients with dual diagnosis in secondary psychiatric care

References

• Todd J, Green G, Harrison M, Ikuesan BA, Self C, Baldacchino A, et al. Defining dual diagnosis of mental illness and substance misuse: Some methodological issues. J Psychiatr Ment Health Nurs 2004;1:48–54.
   Google Scholar
• Morojele NK, Saban A, Seedat S. Clinical presentations and diagnostic issues in dual diagnosis disorders. Curr Opin Psychiatry 2012;3:181–6.
   Web of Science ®Google Scholar
• International Classification of Diseases (ICD). [Accessed June, 2015] Available at: http://www.who.int/classifications/icd/en/.
   Google Scholar
• Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013;8:834–51.
   Web of Science ®Google Scholar
• Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003:183;304–13.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;7:830–42.
   Web of Science ®Google Scholar
• Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull 2000;1:105–18.
   Google Scholar
• Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;19:2511–18.
   Web of Science ®Google Scholar
• Pettinati HM, O'Brien CP, Dundon WD. Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry 2013;1:23–30.
   Web of Science ®Google Scholar
• Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord 2007;12:25–37.
   Web of Science ®Google Scholar
• Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol 2012;22:S499–504.
   PubMed Web of Science ®Google Scholar
• Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: Meta-analytic study. Br J Psychiatry 2009;6:475–82.
   Web of Science ®Google Scholar
• Schmidt LM, Hesse M, Lykke J. The impact of substance use disorders on the course of schizophrenia–a 15-year follow-up study: Dual diagnosis over 15 years. Schizophr Res 2011;13:228–33.
   Web of Science ®Google Scholar
• Aas IH. Guidelines for rating Global Assessment of Functioning (GAF). Ann Gen Psychiatry 2011;10:2.
   PubMed Web of Science ®Google Scholar
• Soderberg P, Tungstrom S, Armelius BA. Reliability of global assessment of functioning ratings made by clinical psychiatric staff. Psychiatr Serv 2005;4:434–8.
   Google Scholar
• Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use among individuals with alcohol use disorders. J Subst Abuse Treat 2009;37:127–37.
   PubMed Web of Science ®Google Scholar
• Assanangkornchai S, Edwards JG. Clinical and epidemiological assessment of substance misuse and psychiatric comorbidity. Curr Opin Psychiatry 2012;3:187–93.
   Web of Science ®Google Scholar
• Wusthoff LE, Waal H, Ruud T, Grawe RW. A cross-sectional study of patients with and without substance use disorders in community mental health centres. BMC Psychiatry 2011;11:93.
   PubMed Web of Science ®Google Scholar
• Hansen SS, Munk-Jorgensen P, Guldbaek B, Solgard T, Lauszus KS, Albrechtsen N, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand 2000;6:432–8.
   Web of Science ®Google Scholar
• Mitchell AJ, Meader N, Bird V, Rizzo M. Clinical recognition and recording of alcohol disorders by clinicians in primary and secondary care: Meta-analysis. Br J Psychiatry 2012;201:93–100.
   PubMed Web of Science ®Google Scholar
• Hjorthoj C, Ostergaard ML, Benros ME, Toftdahl NG, Erlangsen A, Andersen JT, et al. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: A nationwide, prospective, register-based study. Lancet Psychiatry 2015;9:801–8.
   Web of Science ®Google Scholar
• Timko C, Moos RH. Symptom severity, amount of treatment, and 1-year outcomes among dual diagnosis patients. Adm Policy Ment Health 2002;1:35–54.
   Web of Science ®Google Scholar
• Tiet QQ, Mausbach B. Treatments for patients with dual diagnosis: A review. Alcohol Clin Exp Res 2007;492:513–36.
   Google Scholar
• Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012;1:11–24.
   Web of Science ®Google Scholar
• Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry 2012;25:194–200.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M. Psychosocial interventions for people with both severe mental illness and substance misuse. Schizophr Bull 2014;1:18–20.
   Web of Science ®Google Scholar
• Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: Issues and prospects. J Subst Abuse Treat 2008;1:36–47.
   Web of Science ®Google Scholar
• Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;4:469–76.
   Web of Science ®Google Scholar
• Health care in Finland. 2013; Available at: http://urn.fi/URN:ISBN:978-952-00-3395-8.
   Google Scholar
• Berner MM, Kriston L, Bentele M, Harter M. The alcohol use disorders identification test for detecting at-risk drinking: A systematic review and meta-analysis. J Stud Alcohol Drugs 2007;3:461–73.
   Google Scholar
• Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction 1993;6:791–804.
   Web of Science ®Google Scholar
• Haddock G, Barrowclough C, Tarrier N, Moring J, O'Brien R, Schofield N, et al. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial. Br J Psychiatry 2003;183:418–26.
   PubMed Web of Science ®Google Scholar
• Chen S, Barnett PG, Sempel JM, Timko C. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity. J Subst Abuse Treat 2006;1:95–105.
   Web of Science ®Google Scholar
• Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;8:807–16.
   Web of Science ®Google Scholar
• Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, et al. Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry 2012;6:476–84.
   Web of Science ®Google Scholar
• Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, et al. Reliability and validity of DSM-IV axis V. Am J Psychiatry 2000;11:1858–63.
   Web of Science ®Google Scholar
• Statistics Finland. [Accessed June, 2014] Available at: https://www.stat.fi/.
   Google Scholar
• Nordentoft M, Wahlbeck K, Hallgren J, Westman J, Osby U, Alinaghizadeh H, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013;8:e55176.
   PubMed Web of Science ®Google Scholar
• Grau-Lopez L, Roncero C, Daigre C, Miquel L, Barral C, Gonzalvo B, et al. Observational study on medications prescribed to dual-diagnosis outpatients. J Addict Med 2014;2:84–9.
   Web of Science ®Google Scholar
• Teran A, Majadas S, Galan J. Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study. Subst Use Misuse 2008;14:2169–71.
   Web of Science ®Google Scholar
• Pohjanmaa-hanke [Ostrobothnia Depression Study]. 2014; [Accessed May, 2014] Available at: http://www.epshp.fi/pohjanmaahanke/kehittamistyo/paattyneet_kokonaisuudet/hoidon_ja_palveluiden_kehittaminen/kaksoisdiagnoosipotilaan_tunnistaminen_ja_hoito_-koulutussarja_2007-_2008.
   Google Scholar
• Kampman O, Lassila A. Samanaikaisen mielenterveys- ja päihdeongelman hoitoon on kehitetty integroitu arviointimalli [An integrative model for assessing patients with co-morbid mental illness and substance use disorder]. Suom Lääkäril 2007;47:4447–51.
   Google Scholar
• Perälä J. Epidemiology of Psychotic Disorders. Finland: University of Helsinki; 2012.
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2:CD002207.
   PubMed Web of Science ®Google Scholar